Jasper Therapeutics Inc. (JSPRW) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Jasper Therapeutics Inc.

    NASDAQ: JSPRW · Real-Time Price · USD
    0.09
    -0.01 (-14.29%)
    At close: Jun 09, 2025, 3:57 PM

    Jasper Therapeutics Income Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a 1.11M 1.31M 566K
    Gross Profit
    		 n/a -1.11M -1.31M -566K
    Operating Income
    		 -76.24M -68.86M -51.2M -36.83M
    Interest Income
    		 5.06M 5.2M n/a n/a
    Pretax Income
    		 -72.76M -66.09M -37.69M -30.64M
    Net Income
    		 -71.27M -64.47M -24.17M -23.98M
    Selling & General & Admin
    		 20.42M 17.08M 16.57M 11.41M
    Research & Development
    		 55.82M 51.78M 34.63M 25.42M
    Other Expenses
    		 n/a n/a 586K -80K
    Operating Expenses
    		 76.24M 68.86M 51.2M 36.83M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 n/a 68.86M 51.2M 36.83M
    Income Tax Expense
    		 -1.49M -1.63M -13.51M -6.65M
    Shares Outstanding (Basic)
    		 14.58M 10.44M 3.65M 1.14M
    Shares Outstanding (Diluted)
    		 14.58M 10.44M 3.65M 1.14M
    EPS (Basic)
    		 -4.89 -6.18 -6.63 -21.05
    EPS (Diluted)
    		 -4.89 -6.18 -6.63 -21.05
    EBITDA
    		 -71.39M -64.98M -38.21M -31.17M
    EBIT
    		 -72.76M -66.09M -51.2M -36.83M
    Depreciation & Amortization
    		 1.37M 1.11M 1.31M 566K

    Add to Watchlist